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Background: The viral G protein-coupled receptor (vGPCR) is proposed to act as one of the predominant mediators
of Kaposi’s sarcoma (KS), a human herpes virus 8 (HHV8)-elicited disease. The actions of vGPCR manifest pathogenesis,
in part, through increased permeability of endothelial cells. Endothelial cell-cell junctions have indeed emerged as an
instrumental target involved in the vasculature defects observed within the tumor microenvironment. The pathway
leading to adherens junction destabilization has been shown to involve the activation of the small GTPase Rac, in
the context of either latent infection or the sole expression of vGPCR. However, the precise molecular mechanisms
governed by vGPCR in vascular leakage require further elucidation.
Findings: Guanine exchange factors (GEFs) function as critical molecular switches that control the activation of
small GTPases. We therefore screened the effects of 80 siRNAs targeting GEFs on vGPCR-driven endothelial
permeability and identified switch-associated protein 70 (SWAP70) as necessary for its elevating effects. Pull-down
experiments further showed that Rac activation by vGPCR was dependent on SWAP70. Examination of tissues and
cells from HHV8-positive patients revealed that SWAP70 was ubiquitously expressed. Furthermore, SWAP70 was
found to be crucial for vGPCR-driven endothelial tube formation and endothelial sprouting in vitro.
Conclusions: SWAP70 appears to act as a molecular intermediate between vGPCR and endothelial activation.
Because of the important role of vGPCR-mediated endothelial plasticity in KS pathogenesis, inhibition of SWAP70
function could be of interest for blocking vGPCR-driven activities in HHV8-defined diseases.
Keywords: Angiogenesis, Human herpes virus 8, Kaposi sarcoma herpes virus, Permeability, Rac, Small GTPasesFindings
Of the multiple genes encoded by the human herpes
virus 8 (HHV8), the viral G protein-coupled receptor
(vGPCR) is one of the key instigators of Kaposi’s sar-
coma (KS) pathogenesis [1]. vGPCR indeed exhibits
pleiotropic actions in the manifestation of diseases such
as KS and primary effusion lymphoma (PEL), among
which are paracrine transformation and endothelial de-
fects [2-7]. This constitutively active homologue of the
IL-8 chemokine receptor CXCR2 initiates and propa-
gates a KS-like phenotype in mice engineered to express
the gene in an endothelial-restricted manner [2,8,9].
From a molecular standpoint, we have previously demon-
strated that vGPCR exploits the IL-8 pro-permeability* Correspondence: julie.gavard@inserm.fr
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unless otherwise stated.pathway, which involves the activation of the small
GTPase Rac [4,10,11]. In line with this, Rac signaling
has been reported to act upstream of endothelial perme-
ability in latently infected-endothelial cells [6]. More-
over, Rac also controls vGPCR-mediated chemokine and
pro-angiogenic secretion [12], therefore placing Rac at
the cornerstone of vGPCR molecular piracy. Consequently,
interruption of vGPCR/Rac actions could hamper disease
progression in HHV8-infected individuals. However, how
vGPCR orchestrates Rac activation in endothelial cells
is unknown.
We aimed to identify molecular switches involved in
Rac-dependent vGPCR-driven endothelial permeability.
Because vGPCR hijacks IL-8-induced intracellular signal-
ing pathways [1,4,10], we wanted to unmask GEFs that
could contribute to both vGPCR and IL-8 actions. We
thus screened a siRNA library against Rho family GEFs,
which includes Rac GEFs, to pinpoint those required forThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 A functional siRNA library screen identifies 6 putative GEF downstream of vGPCR. A. Schematic of GEF siRNA permeability screen.
B. The fluorescence intensity was determined for each targeting sequence (2 sequences/target) and expressed as means of the ratio to control
siRNA-transfected cells (4 non-silencing control sequences). Shared hits between vGPCR and IL-8 screens are highlighted in red. C. A two-step
screen was performed; the first examined vGPCR-driven permeability. Hits from that screen were then tested for involvement in IL-8-driven
permeability. The six GEFs that significantly decreased permeability when silenced are indicated.
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well-established methodologies, endothelial permeabil-
ity was measured by the passage of FITC-conjugated
40 kDa dextran through a monolayer of human umbil-
ical vein endothelial cells (HUVEC)-expressing vGPCR
(Figure 1A; Additional file 1) [5,13]. The relative change
in fluorescence intensity compared to control sequences
(4 sequences/assay) was then determined for each GEF
siRNA (2 sequences/target, 80 GEFs). Of the eighty
GEFs screened, 29 were identified which, when silenced,
decreased vGPCR-induced permeability by greater than
50% (Figure 1B; Additional file 2: Table S1). Hits from
this first screen were subsequently tested in the context of
IL-8-induced permeability (Figure 1C; Additional file 2:
Table S1) [5,7]. Although two candidates increased per-
meability when silenced, the depletion of six others sig-
nificantly reduced permeability directed by IL-8. The six
GEFs that reduced both IL-8- and vGPCR-mediated
permeability were ABR (active B cell receptor-related),
ARHGEF3, ARHGEF26, dedicator of cytokinesis (DOCK)
8, DOCK10, and switch-associated protein 70 SWAP70
(Figure 1C). ARHGEF3, ARHGEF26, ABR, DOCK8 and
DOCK10, which have not been reported for their ability
to specifically activate Rac, were not considered at thatFigure 2 SWAP70 modulates vGPCR- and IL-8-mediated permeability
stably expressing vGPCR (vGPCR) that were transfected with non-silencing
detected by Rac pulldown in cells with (+) and without (−) vGPCR expressi
non-stimulated SVEC (control) or those stimulated with either VEGF or IL-8
detected by Rac pulldown in cells with (+) and without (−) IL-8 stimulation
three independent experiments. ***p < 0.001; **p < 0.01; ns, non significantstage. Of interest to us was the non-conventional Rac-
GEF, SWAP70 [14]. This protein has been reported to be
involved in various cellular processes including membrane
ruffling, cell-cell adhesion, and migration, as well as cell
proliferation and invasion [14-17]. SWAP70 itself is acti-
vated by the phosphoinositide 3K (PI3K) second messen-
ger, phosphatidylinositol (3,4,5,) P3 (PIP3), which binds its
pleckstrin homology (PH) domain and recruits the pro-
tein to the membrane [14]. Interestingly, both vGPCR
and IL-8 were shown to elevate permeability through
PI3K-dependent Rac activation [4,10], therefore placing
SWAP70 as an appealing candidate.
We first confirmed that silencing SWAP70 impaired
vGPCR-driven endothelial permeability using an inde-
pendent siRNA sequence (Figure 2A). As expected,
vGPCR expression conferred a significantly greater perme-
ability index compared to that of the vGPCR-negative par-
ental cell lines. In sharp contrast, this effect was lost when
SWAP70 was silenced. We next investigated the impact of
SWAP70 on Rac activation. Pull-down experiments re-
vealed a strong activation of Rac in HUVEC-vGPCR cells,
which was mitigated by silencing of SWAP70 (Figure 2B).
Similarly, IL-8 failed to increase permeability and to medi-
ate Rac activation in SWAP70-depleted cells in parentalthrough Rac activation. A. Permeability of SVEC (parental) or SVEC
siRNA (nonsi) or siRNA against SWAP70 (S70si). B. Activated Rac was
on following transfection with nonsi or S70si. C. Permeability of
was determined after transfection S70si or nonsi. D. Activated Rac was
following transfection with nonsi or S70si. Data are representative of
by analysis of variance (ANOVA).
Dwyer et al. Cell Communication and Signaling  (2015) 13:11 Page 4 of 7HUVEC (Figure 2C-D). In contrast, although vascular
endothelial growth factor (VEGF)-driven permeability
was impaired by Rac depletion [4] (Additional file 3:
Figure S1), it was not affected by silencing of SWAP70
(Figure 2C). These data suggest that SWAP70 is neces-
sary for vGPCR- and IL-8-driven endothelial permeabil-
ity likely through its impact on Rac activation.
To examine whether SWAP70 expression may be as-
sociated with HHV8 infection, its gene expression levels
were measured in KS patient-derived tissues, HHV8-
positive cell lines, and KS patient-isolated peripheral B
cells (Figure 3A). SWAP70 RNA was detected in four
KS patient-derived skin lesions (Figure 3A, lanes 2–5) as
well as in the non-KS skin lesion (Figure 3A, lane 1).
Similarly, SWAP70 was present in four latently infected
PEL cell lines (Figure 3A, lanes 6–9), as well as in both
HHV8-positive and-negative patient peripheral B cells
(Figure 3A, lanes 10–11). SWAP70 expression was alsoFigure 3 SWAP70 is expressed in HHV8-infected cells and tissues. A. S
SWAP70 in patient-derived non-KS (Ctrl) and KS skin lesions (KS #1 to #4), a
and patient-isolated KS-positive (KS-B cell) and –negative (Ctrl-B cell) periph
and equal loading. B. Immunohistochemical staining of hematoxylin/eosin
lesions (KS #5 and KS #6) and a KS-negative lesion (angioma).detected by immunohistochemistry in human-derived KS-
positive lesions (as indicated by latent nuclear antigen
(LNA) staining), as well as in non-KS, LNA-negative angi-
oma (Figure 3B). These data demonstrate that SWAP70 is
ubiquitously and homogeneously expressed regardless of
the cell HHV8 status and highlight that SWAP70 is avail-
able for regulation of permeability mediated by vGPCR in
HHV8-defined diseases.
To further evaluate the role of SWAP70 in endothelial
homeostasis in the context of vGPCR expression, pre-
viously established vGPCR-positive SV40-transformed
mouse endothelial cells (SVEC-vGPCR) [4,11] were further
engineered to stably express control- (shC) or SWAP70
targeting shRNAs. SWAP70 sh1 and sh3 sequences effect-
ively impaired SWAP70 messenger expression, when com-
pared with that of either the control (shC) or parental cell
lines (Figure 4A) and were thus used in subsequent ex-
periments. Further supporting our transient knockdownemi-quantitative PCR was used to analyze expression of vGPCR and
s well as in latently infected HHV8 cell lines (BC3, BC1, BCBL1, CROAP6),
eral B cells. GAPDH mRNA levels were detected as a control for input
(H&E) coloration, LNA, and SWAP70 in tissue sections from KS-positive
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Figure 4 SWAP70 is required to convey vGPCR pro-angiogenic actions in endothelial cells. A-D. Parental (Par) and vGPCR-expressing SVEC
(−) were stably transfected with control (shC) or two shRNAs against SWAP70 (sh1 and sh3) plasmids. A. Cells were processed for semi-quantitative
RT-PCR to determine SWAP70 mRNA expression. Actin mRNA levels were detected as a control for input and equal loading. B. Permeability assays were
performed as described in methods. C-D. SVEC cells were also tested for tube formation capacity (C) and sprouting ability (D). Representative
images are shown. Tube length and number of branch points per field of view (FOV) were quantified in C. Number of sprouting cells and mean
sprout length were determined in D. ***p < 0.001, **p < 0.01 by analysis of variance (ANOVA).
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in SVEC significantly impaired vGPCR-induced perme-
ability when compared to shC endothelial lines (Figure 4B).
As another hallmark of endothelial plasticity, the ability
of SVEC to undergo in vitro tubulogenesis was tested
under serum-free conditions [18]. While the parental
SVEC cell line underwent limited tubulogenesis, the
vGPCR-expressing cells readily invaded the matrigel and
formed tubes (Figure 4C). Importantly, although stable
transfection with the control shRNA had no effect onvGPCR-conferred tubulogenesis, this phenotype was vis-
ibly impaired in the SWAP70 knockdown-engineered sh1
and sh3 cell lines (Figure 4C). Quantitation of both tube
length and the number of branching points further sup-
ported these findings (Figure 4C). Accordingly, the cap-
acity of vGPCR-expressing SVEC to attach and sprout
from matrigel-coated beads [19] was also significantly
negatively impacted by SWAP70 silencing (Figure 4D). As
a comparison, parental SVEC sprouting abilities were
clearly limited. Notably, numbers of sprouting cells, as
Dwyer et al. Cell Communication and Signaling  (2015) 13:11 Page 6 of 7well as the mean sprout length, were diminished in
SWAP70-silenced cells (sh1 and sh3), but not in those
of the control shRNA (shC), when compared to SVEC-
vGPCR (Figure 4D). These data therefore suggest that
SWAP70 is necessary for the vGPCR-promoted angio-
genic phenotype of endothelial cells.
In this study, SWAP70 was identified as a protein re-
quired for vGPCR-driven endothelial permeability through
a genetic screen using siRNAs against 80 referenced hu-
man GEFs. In keeping with its conserved role as a GEF
[14,20], it was indeed found that silencing SWAP70
impaired Rac activation mediated by vGPCR, suggesting
that SWAP70 functions downstream of vGPCR to
modulate the Rac activation state. SWAP70 was also ne-
cessary for IL-8-driven endothelial permeability and Rac
activation. Because IL-8 signals through CXCR2, the hu-
man homologue of vGPCR, this suggests that vGPCR
fully mimicked CXCR2 signaling by pirating the SWAP70/
Rac axis in endothelial cells [4,10]. As mentioned earlier,
SWAP70 recruitment to the plasma membrane, which is a
prerequisite for GEF enzymatic activity, involves the PI3K
second messenger PIP3 [14]. Both vGPCR and CXCR2
drive endothelial permeability via the PI3K-Rac signal-
ing nexus [4,10,11], SWAP70 might therefore fit down-
stream of PI3K in vGPCR/CXCR2-driven permeability
pathway activation.
SWAP70 was also necessary for vGPCR-mediated endo-
thelial tubulogenesis and sprouting. These two assays
measure the migratory and invasive capacity of endothelial
cells as an indicator of angiogenic potential and plasticity.
Thus, SWAP70 appears to be essential for the angiogenic
phenotype imposed on endothelial cells by vGPCR [1,2,7].
In keeping with this idea, SWAP70 also regulates migra-
tion and invasion in various immune cells [15,21,22]. In
dendritic cells, for example, it transmits migratory and in-
vasive signals elicited by sphingosine-1 phosphate [23].
SWAP70 also influences these processes in glioma and
prostate cancer cells [24,25]. In these cases, depletion of
SWAP70 correlated with both reduced cell migration and
invasion [24,25]. Conversely, co-expression of SWAP70
with oncogenic v-Src in mouse embryonic fibroblasts has
been shown to result in a more aggressive and invasive
phenotype than when v-Src is expressed alone [17]. Thus
although SWAP70 is widely expressed and functional, it
seems that its deregulation as a result of its exploitation
by oncogenes, in this case vGPCR, could promote the de-
velopment of more aggressive tumors.
It should be mentioned that five additional GEFs were
identified in the screen that also impaired vGPCR/IL-8-
induced permeability. Owing to their lack of reported
Rac GEF activity, they were not further explored. How-
ever, it is interesting to speculate that they potentially
play additive roles in vGPCR-promoted permeability via
Rac-independent pathways. Thus their role in vGPCR-promoted permeability should be deciphered in future
studies.
In summary, this study identifies the Rac GEF SWAP70
as a mediator of permeability downstream of both vGPCR
and IL-8. Blockade of SWAP70 function could be of
therapeutic value to prevent permeability and activation of
endothelial cells and thus hinder tumor angiogenesis.
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